AZD7798 Safety, Tolerability, and Pharmacokinetics after a single dose administration to healthy subjects

Trial Identifier: D9690C00001
Sponsor:AstraZeneca
Collaborator:
Parexel
NCTID:NCT05452304
Start Date:July 2022
Primary Completion Date: September 2023
Study Completion Date: September 2023
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

CountryLocation
GB Harrow, GB, HA1 3UJ